Drug Report History #136515
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v5-EN | Version v2-FR |
|---|---|---|
| Language | English (Updated) | French |
| Date Updated | 2021-08-06 (Updated) | 2021-03-29 |
| Drug Identification Number | 02242527 | 02242527 |
| Brand name | SANDOZ PROCTOMYXIN HC | SANDOZ PROCTOMYXIN HC |
| Common or Proper name | SANDOZ PROCTOMYXIN HC | SANDOZ PROCTOMYXIN HC |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | HYDROCORTISONE DIBUCAINE HYDROCHLORIDE FRAMYCETIN SULFATE ESCULIN | HYDROCORTISONE DIBUCAINE HYDROCHLORIDE FRAMYCETIN SULFATE ESCULIN |
| Strength(s) | 0.5% 0.5% 1% 1% | 0.5% 0.5% 1% 1% |
| Dosage form(s) | OINTMENT | OINTMENT |
| Route of administration | RECTAL RECTAL | RECTAL RECTAL |
| Packaging size | 30g OIN CA | 30g OIN CA |
| ATC code | C05AA | C05AA |
| ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2021-03-26 | 2021-03-26 |
| Estimated end date | Unknown | Unknown |
| Actual end date | 2021-08-05 (Updated) | |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | product discontinued (Updated) | |
| Health Canada comments |